|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 497.84 USD | +0.22% |
|
+6.04% | +9.57% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 548.69 | +10.46% | 29 | ||||||
| 1,220.39 | +1.75% | 28 | ||||||
| 257.5 | +1.39% | 22 | ||||||
| 256.14 | +1.79% | 28 | ||||||
| 358.94 | +7.86% | 18 | ||||||
| 218.36 | +16.72% | 22 | ||||||
| 154.36 | -1.47% | 21 | ||||||
| 315.24 | +0.2% | 24 | ||||||
| 354.76 | -2.03% | 29 | ||||||
| 157.67 | +24.8% | 27 | ||||||
| 29.15 | +21.06% | 27 | ||||||
| 63 | +9.34% | 24 | ||||||
| 20.93 | +5.66% | 19 | ||||||
| 96.7 | +28.8% | 23 | ||||||
| 9,973.33 | +32.38% | 15 | ||||||
| 81.14 | +55.92% | 16 | ||||||
| 6,106.87 | +18.46% | 15 | ||||||
| 4.136 | +18.97% | 17 | ||||||
| 434.72 | +44.41% | 25 | ||||||
| Average | 1,086.95 | +15.60% | 23 | ||||||
| Weighted average by Cap. | 707.8 | +7.14% | 24 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
